Specialty pharmacies and online companies were selling the off-brand copies while there was a shortage of Zepbound and Mounjaro.

The ever-increasing use of GLP-1 agonists is uncovering clues about what else they can do. One out of 20 prescriptions written in the U.S. is for a GLP-1 drug. US doctors write billions of ...

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).

The use of NSAIDs for symptomatic management of uncomplicated UTIs probably results in less short-term resolution of symptoms and greater use of rescue antibiotics by day 30 compared to primary ...

The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...

The U.S. Food and Drug Administration on Wednesday approved Mesoblast's cell therapy for treating a type of complication that ...

The new gene therapies for sickle cell disease—including the gene-editing treatment Casgevy, based on research at Boston ...

Harrow's relaunch of Triesence, a preservative-free corticosteroid, is revolutionizing ophthalmology with safer and more ...